Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "MitoCom Events"

From Bioblast
Line 4: Line 4:




==Ankündigungen==
== ''MitoCom'' Announcements ==


* Open position: [http://www.i-med.ac.at/public-relations/news/jobs/Projekt-MitoCom_Stellenausschreibung_CTA-BMA.pdf Technical Assistant]
* Open position: [http://www.i-med.ac.at/public-relations/news/jobs/Projekt-MitoCom_Stellenausschreibung_CTA-BMA.pdf Technical Assistant]
Line 21: Line 21:
* [[MitoCom lectures|Introduction to mitochondrial respiratory physiology]]
* [[MitoCom lectures|Introduction to mitochondrial respiratory physiology]]


== ''MitoCom'' Track Record ==
=== 2011-10-20 to 21: Targeting Mitochondria, Berlin, DE ===
* Invited lecture: Erich Gnaiger - [[Gnaiger 2011 Abstract Berlin]]
* Exhibition of OROBOROS INSTRUMENTS and ''MitoCom Tyrol'': Katrin Stecher, Lyda Staudacher


=== 2011-09-24: High-output to replace wasteful high-throughput? ===
=== 2011-09-24: High-output to replace wasteful high-throughput? ===


* [[Talk:Rogers 2011 PlosOne|Discussion: OROBOROS O2k versus Seahorse XF]]
* [[Talk:Rogers 2011 PlosOne|Discussion: OROBOROS O2k versus Seahorse XF]]


=== 2011-09-05 to 04: MiP2011 Bordeaux, France ===
=== 2011-09-05 to 04: MiP2011 Bordeaux, France ===
Line 33: Line 38:
* Poster: Erich Gnaiger - [[Lemieux_2011_Abstract Bordeaux]]
* Poster: Erich Gnaiger - [[Lemieux_2011_Abstract Bordeaux]]
* Poster: Mario Fasching - [[Fasching_2011_Abstract Bordeaux]]
* Poster: Mario Fasching - [[Fasching_2011_Abstract Bordeaux]]
* Exhibition of the OROBOROS Oxygraph-2k: Katrin Stecher and Lydia Staudacher
* Exhibition of OROBOROS INSTRUMENTS and ''MitoCom Tyrol'': Katrin Stecher, Lyda Staudacher
 


=== 2011-08-31 to 09-04: KAGOSHIMA JAPAN ===
=== 2011-08-31 to 09-04: KAGOSHIMA JAPAN ===
Line 41: Line 45:
* Invited lecture: Erich Gnaiger - [[Sumbalova 2011 Abstract Kagoshima]]
* Invited lecture: Erich Gnaiger - [[Sumbalova 2011 Abstract Kagoshima]]
* Exhibition of the OROBOROS Oxygraph-2k: Yoshiaki Nakayoshi, Sanyo Trading Co. Ltd., Tokyo, JP
* Exhibition of the OROBOROS Oxygraph-2k: Yoshiaki Nakayoshi, Sanyo Trading Co. Ltd., Tokyo, JP


=== 2011-08-26 to 27: O2k-Workshop China ===
=== 2011-08-26 to 27: O2k-Workshop China ===
* [http://www.oroboros.at/index.php?nextcourse#c3191 O2k-Workshop on High-Resolution Respirometry, Beijing and Tianjin, China]
* [http://www.oroboros.at/index.php?nextcourse#c3191 O2k-Workshop on High-Resolution Respirometry, Beijing and Tianjin, China]


=== 2011-08-12: Circular on MitoScore ===
=== 2011-08-12: Circular on MitoScore ===
Line 51: Line 53:
'''[[MitoScore]]''' is an initiative of ''MitoCom'':
'''[[MitoScore]]''' is an initiative of ''MitoCom'':
* [[File:Network MitoScore.pdf]]
* [[File:Network MitoScore.pdf]]


=== 2011-08-09: Manuscript accepted for publication in IJBCB ===
=== 2011-08-09: Manuscript accepted for publication in IJBCB ===
Line 59: Line 60:
** Reviewer #2: "'''''This is a beautifully written work, replete with well-designed experiments and, within the space limitations, a nice review of the pertinent literature.'''  The demonstration of impaired mitochondrial fatty acid oxidation in early stages of human failure is very important, as is the demonstration of defects in the phosphorylation system and Complex I-linked respiration.''"
** Reviewer #2: "'''''This is a beautifully written work, replete with well-designed experiments and, within the space limitations, a nice review of the pertinent literature.'''  The demonstration of impaired mitochondrial fatty acid oxidation in early stages of human failure is very important, as is the demonstration of defects in the phosphorylation system and Complex I-linked respiration.''"
** Reviewer #3: "'''''The manuscript belongs literally to the symphony of bioenergetics''' and have mastered on a maximum thorough and detailed level a priority study of human heart disease bioenergetics in an intermediate state of heart disease, which was done only scarcely in medical sciences and for this orthodox approach this work deserves a high attention.  It elegantly describes detailed oxidative phosphorylation parameters in heart disease compared to the control human heart.  Using high-resolution respirometry of permeabilized human heart muscle fibres authors progressively describe distinct aspect of measured data in logical steps to present important differences of diminished mitochondrial function during heart failure. Using elegant protocols developed for years, authors distinguish between phosphorylating (OXPHOS) and non-phosphorylating (ETS) conditions with both complex I and II input using physiological substrates of glucose and lipid oxidation. With presented protocols, authors are able to provide conclusions regarding,  e.g., complex I impairment, phosphorylation system limitation (3.2) mitochondrial content (3.3), leak respiration involvement, etc., besides OXPHOS and ETS capacities. Authors use their own terminology describing respiratory states. It would be useful to explain briefly their terminology also in terms of the canonical state 2 - 4 terminology. In spite of this, the methodology approach and presented data are well explained.''"
** Reviewer #3: "'''''The manuscript belongs literally to the symphony of bioenergetics''' and have mastered on a maximum thorough and detailed level a priority study of human heart disease bioenergetics in an intermediate state of heart disease, which was done only scarcely in medical sciences and for this orthodox approach this work deserves a high attention.  It elegantly describes detailed oxidative phosphorylation parameters in heart disease compared to the control human heart.  Using high-resolution respirometry of permeabilized human heart muscle fibres authors progressively describe distinct aspect of measured data in logical steps to present important differences of diminished mitochondrial function during heart failure. Using elegant protocols developed for years, authors distinguish between phosphorylating (OXPHOS) and non-phosphorylating (ETS) conditions with both complex I and II input using physiological substrates of glucose and lipid oxidation. With presented protocols, authors are able to provide conclusions regarding,  e.g., complex I impairment, phosphorylation system limitation (3.2) mitochondrial content (3.3), leak respiration involvement, etc., besides OXPHOS and ETS capacities. Authors use their own terminology describing respiratory states. It would be useful to explain briefly their terminology also in terms of the canonical state 2 - 4 terminology. In spite of this, the methodology approach and presented data are well explained.''"


=== 2011-07-12: The K-Regio MitoCom project - accepted ===
=== 2011-07-12: The K-Regio MitoCom project - accepted ===
*The project application [[MitoCom_K-Regio|''MitoCom Tyrol'']] was officially accepted.
*The project application [[MitoCom_K-Regio|''MitoCom Tyrol'']] was officially accepted.


=== 2011-07-12: Manuscript accepted in AJP ===
=== 2011-07-12: Manuscript accepted in AJP ===
* "'''Similar qualitative and quantitative changes of mitochondrial respiration following strength and endurance training in normoxia and hypoxia in sedentary humans'''" by '''Pesta D, Hoppel F, Macek C, Messner H, Faulhaber M, Kobel C, Parson W, Burtscher M, Schocke M, Gnaiger E''' was accepted for publication in ''Am. J. Physiol. Regul. Integr. Comp. Physiol.'' (http://www.ncbi.nlm.nih.gov/pubmed/21775647).   
* "[[Pesta_2011_AJP|Similar qualitative and quantitative changes of mitochondrial respiration following strength and endurance training in normoxia and hypoxia in sedentary humans" by Pesta D, Hoppel F, Macek C, Messner H, Faulhaber M, Kobel C, Parson W, Burtscher M, Schocke M, Gnaiger E]], was accepted for publication in ''Am. J. Physiol. Regul. Integr. Comp. Physiol.'' (http://www.ncbi.nlm.nih.gov/pubmed/21775647).   
* From the anonymous referee's comments: '''This is really a superb revision; the MS has been improved substantially, particularly with reference to the theory and methods re: the HRR.'''
* From the anonymous referee's comments: ''This is really a superb revision; the MS has been improved substantially, particularly with reference to the theory and methods re: the HRR.''
 


=== 2011-07-11 to 13: Introductory O2k-Workshop (IOC62) -  MitoCom Tyrol ===
=== 2011-07-11 to 13: Introductory O2k-Workshop (IOC62) -  MitoCom Tyrol ===
* Location: OROBOROS INSTRUMENTS, Schöpfstr. 18, Innsbruck, Austria.
* Location: OROBOROS INSTRUMENTS, Schöpfstr. 18, Innsbruck, Austria.
* More informatio: [[IOC62]]
* More informatio: [[IOC62]]


=== 2011-06-15 to 18: UMDF Mitochondrial Medicine 2011 - Chicago, US ===
=== 2011-06-15 to 18: UMDF Mitochondrial Medicine 2011 - Chicago, US ===
Line 79: Line 76:
* Poster: Dominik Pesta - [[Pesta_2011_AbstractUMDFChicago-Training]]
* Poster: Dominik Pesta - [[Pesta_2011_AbstractUMDFChicago-Training]]
* Poster: Dominik Pesta - [[Pesta_2011_AbstractUMDFChicago-Diagnosis]]
* Poster: Dominik Pesta - [[Pesta_2011_AbstractUMDFChicago-Diagnosis]]
* Exhibition of OROBOROS INSTRUMENTS and ''MitoCom Tyrol'': Katrin Stecher, Dominik Pesta, Erich Gnaiger


 
=== 2011-05-01: Start K-Regio Project ''MitoCom Tyrol'' ===
==2011-05-01: Start K-Regio Project ''MitoCom Tyrol''==




::''MitoCom'' announcements
== ''MitoCom'' Announcements ==




==2012-12-12 to 15: Crystals in Mitochondrial Competence==
=== 2012-12-12 to 15: Crystals in Mitochondrial Competence ===
* Conference on [[Crystals in Mitochondrial Competence]]
* Conference on [[Crystals in Mitochondrial Competence]]
* Location: Alpbach, Tyrol, Austria
* Location: Alpbach, Tyrol, Austria




::See also: [[MitoCom past events]]
  See also: [[MitoCom past events]]

Revision as of 21:54, 26 October 2011

Template:MitoCom



MitoCom Announcements

  • 2011-11-29: Innovationstag der Standortagentur Tirol: Präsentation von MitoCom Tyrol.


2011-November: MitoCom Lectures, Innsbruck


MitoCom Track Record

2011-10-20 to 21: Targeting Mitochondria, Berlin, DE

  • Invited lecture: Erich Gnaiger - Gnaiger 2011 Abstract Berlin
  • Exhibition of OROBOROS INSTRUMENTS and MitoCom Tyrol: Katrin Stecher, Lyda Staudacher

2011-09-24: High-output to replace wasteful high-throughput?

2011-09-05 to 04: MiP2011 Bordeaux, France

2011-08-31 to 09-04: KAGOSHIMA JAPAN

2011-08-26 to 27: O2k-Workshop China

2011-08-12: Circular on MitoScore

MitoScore is an initiative of MitoCom:

2011-08-09: Manuscript accepted for publication in IJBCB

  • "Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart" (by Lemieux H, Semsroth S, Antretter H, Höfer D, Gnaiger E) was accepted for publication in Intl. J. Biochem. Cell Biol.
  • From the anonymous referee's comments:
    • Reviewer #1: "The manuscript by Lemieux and colleagues offers interesting insight into the bioenergetics of early phases of heart failure."
    • Reviewer #2: "This is a beautifully written work, replete with well-designed experiments and, within the space limitations, a nice review of the pertinent literature. The demonstration of impaired mitochondrial fatty acid oxidation in early stages of human failure is very important, as is the demonstration of defects in the phosphorylation system and Complex I-linked respiration."
    • Reviewer #3: "The manuscript belongs literally to the symphony of bioenergetics and have mastered on a maximum thorough and detailed level a priority study of human heart disease bioenergetics in an intermediate state of heart disease, which was done only scarcely in medical sciences and for this orthodox approach this work deserves a high attention. It elegantly describes detailed oxidative phosphorylation parameters in heart disease compared to the control human heart. Using high-resolution respirometry of permeabilized human heart muscle fibres authors progressively describe distinct aspect of measured data in logical steps to present important differences of diminished mitochondrial function during heart failure. Using elegant protocols developed for years, authors distinguish between phosphorylating (OXPHOS) and non-phosphorylating (ETS) conditions with both complex I and II input using physiological substrates of glucose and lipid oxidation. With presented protocols, authors are able to provide conclusions regarding, e.g., complex I impairment, phosphorylation system limitation (3.2) mitochondrial content (3.3), leak respiration involvement, etc., besides OXPHOS and ETS capacities. Authors use their own terminology describing respiratory states. It would be useful to explain briefly their terminology also in terms of the canonical state 2 - 4 terminology. In spite of this, the methodology approach and presented data are well explained."

2011-07-12: The K-Regio MitoCom project - accepted

2011-07-12: Manuscript accepted in AJP

2011-07-11 to 13: Introductory O2k-Workshop (IOC62) - MitoCom Tyrol

  • Location: OROBOROS INSTRUMENTS, Schöpfstr. 18, Innsbruck, Austria.
  • More informatio: IOC62

2011-06-15 to 18: UMDF Mitochondrial Medicine 2011 - Chicago, US

2011-05-01: Start K-Regio Project MitoCom Tyrol

MitoCom Announcements

2012-12-12 to 15: Crystals in Mitochondrial Competence


 See also: MitoCom past events
Retrieved from "https://wiki.oroboros.at/index.php?title=MitoCom_Events&oldid=17280"
Powered by MediaWiki
Powered by Semantic MediaWiki